Numerous molecular markers already discovered and are known to affect breast cancer outcomes include Estrogen Receptor (ER), Progesterone Receptor (PR) from the steroid hormone receptor pathway and human epidermal growth factor in the HER family. This evidence concerns the gene ESR1 and breast carcinoma.